Resumo

FARFALLI, Germán L et al. Metástasis pulmonares en osteosarcoma neoadyuvancia, tratamiento quirúrgico y supervivencia. Medicina (B. Aires) [online]. 2015, vol.75, n.2, pp.87-90. ISSN 0025-7680.

Five years overall survival in osteosarcoma patients is around 70%, although in patients with metastatic disease it is only 10-30%. The objective of this study was to analyze overall survival and prognostic factors in a group of patients with metastatic osteosarcoma treated with surgical removal of the lung metastases. A retrospective review from our oncology data base revealed 38 patients treated between 1992 and 2006. The mean age at diagnosis was 18 ± 9.4 years (3-45) and mean follow-up was 57 ± 53.8 months (12-231). All patients were treated with chemotherapy and oncologic resection of the primary tumor and surgical removal of the lung metastases. We analyzed overall survival and prognostic factors: age, gender, site, time of metastasis, local recurrences, number of lung metastasis and chemotherapy response (necrosis). Overall survival of the entire series was 29% at 5 years (CI95%: 14.5-43.5) and 26% at 10 years (CI95%: 12-40). Significant difference in 5 year overall survival was found between good and bad responders to chemotherapy, 53% (IC95%: 28-78) vs. 8% (IC95%: 0-20) (p = 0.0008). No statistically significant relationship between other prognostic factors analyzed was observed. Five and ten years overall survival rates in osteosarcoma patients with lung metastasis treated with chemotherapy and surgically resection is poor. Patients with good response to chemotherapy have better prognosis.

Palavras-chave : Osteosarcoma; Lung metastasis; Meoadjuvant chemotherapy; Surgical resection.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )